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Abstract Macrophages are present in mammals from
midgestation, contributing to physiologic homeostasis
throughout life. Macrophages arise from yolk sac and foetal
liver progenitors during embryonic development in the mouse
and persist in different organs as heterogeneous, self-renewing
tissue-resident populations. Bone marrow-derived blood
monocytes are recruited after birth to replenish tissue-
resident populations and to meet further demands during in-
flammation, infection and metabolic perturbations.
Macrophages of mixed origin and different locations vary in
replication and turnover, but are all active in mRNA and pro-
tein synthesis, fulfilling organ-specific and systemic trophic
functions, in addition to host defence. In this review, we em-
phasise selected properties and non-immune functions of tis-
sue macrophages which contribute to physiologic
homeostasis.
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Introduction
BThe constancy of the internal environment is the condition
for full and independent life: the mechanism that makes it
possible is that which assured that maintenance, within the
internal environment, conditions necessary for the life of these
elements^ (Claude Bernard).
The concept of homeostasis as a physiological principle, a
term proposed by the neuroscientist Walter Cannon (1871–
1945) and based on the work of Claude Bernard (1813–
1878), has influenced the thinking of many macrophage in-
vestigators. Elie Metchnikoff (1845–1916), a comparative zo-
ologist who initially was intrigued by intracellular digestion in
invertebrates, became an experimental immunologist when he
appreciated the role of phagocytes in tissue orthobiosis and
inflammation [67]. Hans Selye (1907–1982) drew attention to
the non-specific neuro-endocrine adaptations of the body to
biological stress; however, the contributions of the mononu-
clear phagocyte system to the mechanisms of homeostasis and
stress responses have not achieved full recognition. In this
review, we consider topics related to the role of macrophages
in development, metabolism and tissue-specific functions in
different organs, to illustrate their remarkable ability to recog-
nise and respond to the changing needs of the body. A general
overview of the main topic covered is provided in Fig. 1.
Blood monocytes and tissue macrophages display many
properties in common, but they adapt readily upon entering
different tissue microenvironments, where they contribute to
the general needs as well as specialised functions of individual
organs. Reciprocal interactions between neighbouring cells
and tissue macrophages are mediated by close contacts as well
as secretory products which act at close range or distally via
the circulation. Although primarily known as professional
phagocytes [29], which engulf dying cells during develop-
ment and subsequently during adult life, it has not been
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generally appreciated that macrophage activities extend be-
yond immunology and host defence. They express a broad
repertoire of surface and intracellular receptors and produce
a large variety of regulated bioactive molecules; together with
their ability to enter all tissues, in the steady state and on
demand, they constitute a dispersed organ system, able to
influence and respond to every other system in the body.
Cellular characteristics of the macrophage lineage:
relevance to physiology
To set the stage for subsequent discussion, we briefly summa-
rise some general properties of macrophages relevant to their
functions in vivo. The cells originate from progenitors in the
embryo and postnatally, as discussed further below, and are
seeded throughout the body as relatively long lived, terminally
differentiated haematopoietic cells. They are motile and dis-
play a range of membrane receptors to recognise and respond
to a large repertoire of host-derived and foreign ligands [29].
These include adhesion molecules, opsonic and non-opsonic
receptors to mediate phagocytic clearance of particulates, in-
cluding micro-organisms and apoptotic cells, and for endocy-
tosis of soluble ligands. In addition, they are able to sense and
respond to the presence of microbial constituents, including
RNA and DNA, within their cytoplasm, activating intracellu-
lar inflammasomes [32], caspase processing and release of IL-
1β. A plethora of other cytokines, enzymes, growth factors,
lipid-derived and low molecular metabolite products can also
be secreted by macrophages in response to phagocytic and
various stimuli and, in turn, act on macrophage receptors by
autocrine mechanisms. Plasma membrane receptors co-
operate in formation of a phagocytic synapse, excluding phos-
phatases such as CD45, and allow receptor kinases to initiate
signalling pathways and cytoskeletal assembly, to bring about
ingestion of particles [21]. A sequence of dynamic interac-
tions with vesicular membranes derived from the endoplasmic
reticulum and Golgi apparatus accompanies phagosome mat-
uration, fusion with primary lysosomes, acidification and di-
gestion [31, 39, 71]. Macrophages can internalise its entire
surface membrane in 20 min, but recycle components equally
rapidly to maintain membrane homeostasis [51]. Heterophagy
Fig. 1 Physiological roles of macrophages and macrophages
heterogeneity. Phenotypic heterogeneity of tissue macrophages is
triggered by differences in cellular origin (self-replicated cells of
embryonic origin vs monocyte-derived), tissue environment and
adaptation to the physiological requirements of the organism (shown on
the left). Macrophage heterogeneity underpins the vast range of
physiological roles performed of these cells (shown on the right).
Phenotypic heterogeneity is consolidated by tissue-specific Bchromatin
landscapes^ in macrophages in response to environmental signals.
Macrophages display a wide range of Bsensor systems^ in the form of
(a) cell surface and intracellular pattern recognition receptors that detect
microbe-associated molecular patterns and damage-associated molecular
patterns; (b) receptors for apoptotic cells; (c) cytokine receptors such as
IFN-γ and IL-4Rα that promote M1/M2-like activation, respectively; (d)
receptors for neurotransmitters as well as (e) receptors that regulate
macrophage activation in situ such as the inhibitory receptors SIRP1-α
and CD200R. Integrins (f) mediate interaction with extracellular matrix.
Macrophages produce numerous molecules that contribute to tissue
remodelling and inflammation and mediate clearance of apoptotic
bodies, cell debris and soluble compounds such as collagen and
lysosomal hydrolases. High phagocytic and endocytic activities as well
as motility are central to the ability of macrophages to support tissue-
dependent functions. RNS reactive nitrogen species, ROS reactive
oxygen species
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refers to uptake of extracellular cargo; autophagy, the seques-
tration of effete cytoplasm and intracellular organelles, is well
developed in macrophages [16]; genetic deficiency of lyso-
somal digestion or components of the autophagy pathway can
result in storage diseases [59] or chronic granulomatous in-
flammation [68], respectively.
The uptake and killing of microbes and opsonised cellular
targets by oxygen and nitrogen-derived radicals are mediated
by assembly and activation of an NADPH oxidase and induc-
ible nitric oxide synthetase, respectively [23, 43]. The inges-
tion of apoptotic targets, a major physiologic function of
tissue-resident and inflammatory macrophages, is mediated
by a range of redundant receptors, using exposed phosphatidyl
serine and other cues as ligands [2]. Apoptotic cell uptake
inhibits the inflammatory response associated with uptake of
necrotic cells or microbes; anti-inflammatory products include
TGF-β, IL-10 and PGE2 [38]. The importance of phagoptotic
killing during phagocytosis has been emphasised by the stud-
ies of Guy Brown and colleagues [7]. Finally, macrophages
can ingest membrane-enveloped nuclei or intracellular vesi-
cles released from living cells or undergo cell fusion, to form
multinucleated giant cells [35].
Phenotypic adaptation of macrophages
Macrophage gene expression has been intensively studied in
recent years and modules of genes regulated by a range of
cytokines and other stimuli characterised in tissue-resident
and inflammatory macrophages. Both pro- and anti-
inflammatory pathways can be induced in macrophage popu-
lations, mediated by plasma membrane or cytoplasmic recep-
tors. IFN-γ, for example, induces a characteristic profile of
genes and proteins, often termed Bclassical or M1 activation^
[47]; prototypic markers include upregulation of MHCII anti-
gens, pro-inflammatory cytokines and induction of i-NOS,
whereas CD206 expression is selectively downregulated. By
contrast, interleukin-4 and interleukin-13, binding to a com-
mon IL-4 receptor alpha chain, induce an Balternative, M2^
phenotype, characterised by upregulation of CD206,
transglutaminase 2, arginase and, in the mouse, chitinase-
like molecules such as YM1 [48]. An IL-13-specific receptor
pathway has also been demonstrated by induction of macro-
phage homokaryon formation [62]. Phenotypic changes in
macrophages are underpinned by metabolic reprogramming.
M1 macrophages utilise Warburg metabolism and M2 macro-
phage oxidative metabolism [55]. The M1/M2 terminology
arose as counterpart to Th1 and Th2 categories of adaptive
immune responses, associated with the above and related cy-
tokines. It is thought that instead of bimodal polarisation, a
more complex phenotypic spectrum is more likely, especially
in vivo [50, 52]. In truth, there is overlap with other cytokine-
induced stimuli, e.g. after IL-10 stimulation or immune
complex activation [19]. The stability or reversibility of phe-
notype in vivo needs a great deal of further study, at popula-
tion and the single cell level. In addition, further studies on
genetic and epigenetic mechanisms will contribute to a more
sophisticated understanding of tissue-specific and generic
macrophage phenotypic heterogeneity.
Macrophage heterogeneity under physiological
conditions
The immune system comprises a complex network of cellular
and soluble components that collaborate to respond to chal-
lenges, both infectious and non-infectious, identified as poten-
tial threats to the organism. Accordingly, immune constituents
are widely distributed throughout tissues with specialised lym-
phoid organs, such as splenic white pulp and lymph nodes,
mostly providing unique sites for the induction of specific
acquired immunity.
To date, newcomers to the field are still surprised to learn
that healthy tissues incorporate immune cells, in particular,
macrophages which are cells commonly associated with pro-
tection against infection and as mediators of tissue damage.
Macrophages, unlike neutrophils, are integral components of
tissues; they contribute to organ development and mainte-
nance of homeostasis through mechanisms similar to those
exploited during infection to detect pathogens and trigger in-
flammation. Widespread distribution of macrophages is ac-
companied by substantial tissue-specific phenotypic and gene
expression profile differences related to the specific environ-
mental cues in each organ that foster tissue-specific macro-
phage function [25]. Differences in gene expression are
underpinned by the existence of distinct Bchromatin
landscapes^ in each tissue macrophage population which are
determined in large extent by the tissue environment [44].
Furthermore, fully differentiated macrophages may retain the
capacity to change their gene expression profile when exposed
to a new tissue environment [44], which highlights the poten-
tial ability of macrophages to undergo reprogramming even
after differentiation. Phenotypically, there are instances of tis-
sue adaptation in macrophages involving fine tuning of cellu-
lar activation thresholds. In mucosal tissues such as the respi-
ratory and gastrointestinal tracts, macrophages display a
higher threshold of activation as a means to minimise
inflammation-mediated organ damage in response to repeated
exposure to foreign material, including microbial products. In
the case of alveolar macrophages, exposure to IL-10, surfac-
tant proteins A and D and close interaction with respiratory
epithelium through the inhibitory receptor CD200R and ανβ-
6 tethered TGF-β, act as effective brakes of macrophage ac-
tivation minimising the risk of unwanted inflammation [40].
In the gut, macrophages are hyporesponsive to stimulation
[65]. Nevertheless, gut macrophages can trigger inflammation
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with one mechanism involving the detection of tissue damage
through activation of the NLRC4 inflammasome which in-
duces processing of pro-IL-1β constitutively expressed by
intestinal macrophages [20]. This mechanism ensures detec-
tion of pathogens that cause tissue damage through the pro-
duction of virulence factors [6, 70]. Macrophages in internal
organs, less exposed to microbial constituents, present a lower
activation threshold and are considered to be responsible for
the induction of systemic inflammation in response to blood-
borne pathogens, which can have deadly consequences in the
case of sepsis [30].
Origin of tissue macrophages
In addition to tissue-specific environmental cues, tissue-
specific characteristics in macrophages can be linked in part
to on site differentiation of macrophages from embryonic pre-
cursors during development and maintenance of macrophage
numbers in tissues through self-renewal [26, 63] with imprint-
ing of macrophage transcriptional programmes by tissue fac-
tors of particular importance [26]. Indeed, the original idea of
monocytes as precursors of tissue macrophages that gave rise
to the concept of Bthe mononuclear phagocyte system^ pro-
posed by van Furth et al. 1974 has been questioned by recent
studies demonstrating that in many anatomical sites, tissue
macrophages originate from precursors derived from the yolk
sac during early embryogenesis with a second wave of embry-
onic precursors derived from foetal liver. This embryonic or-
igin contrasts with the bone marrow origin for most immune
cells [18, 26, 33]. Definitive haematopoiesis takes place in the
bone marrow after birth. These findings were accompanied by
the identification in the mouse of two populations of circulat-
ing monocytes: classical Ly6chi monocytes that originate di-
rectly from Ly6c + precursors and non-classical Ly6clow
monocytes that derive from Ly6chigh monocytes through the
action of the transcription factor Nr4a1 [18]. Further, mono-
cytes are now perceived to be not just transitional cells on their
way to tissues; some authors refer to circulating Ly6Clo mono-
cytes as Bblood macrophages^ involved in the maintenance of
the integrity of the endothelial barrier [33]. Ly6Chigh mono-
cytes contribute to replenishment of tissue macrophages with
the rate of replenishment varying among anatomical sites. In
the steady state, monocyte-derived tissue macrophages are
almost non-existent in the case of brain as microglia are de-
rived from yolk sac precursors. Similar scenarios have been
observed in the case of Langerhans cells in the epidermis,
alveolar macrophages in the lung andKupffer cells in the liver.
Monocyte-derived resident macrophages are more prevalent
in the heart and pancreas (which display a slow replacement
rate) and gut and dermis (which display a higher replacement
rate) [26, 63].
Ly6Chigh monocytes are recruited to tissues under steady
state and inflammatory conditions. In the absence of inflam-
mation, Ly6Chigh monocytes sample the tissues and transport
material to draining lymph nodes without differentiating into
macrophages or dendritic cells [18]. Under inflammatory con-
ditions, Ly6Chigh monocytes differentiate into macrophages
and can give rise to tissue macrophages with capacity for
self-renewal. This process is highly dependent on the tissue-
depletion strategy used and the organ under consideration
[18].
Role of macrophages in development
Osteoclasts and bone remodelling
Bone remodelling occurs throughout life and is influenced by
physical activity, diet and hormones. Bone generation, pro-
moted by cells of mesenchymal origin termed osteoblasts, is
balanced by the action of cells of haematopoietic origin
termed osteoclasts that mediate bone reabsorption. Bone for-
mation and degradation need to be balanced as disequilibrium
would lead to osteoporosis (loss of bone mass) or
osteopetrosis (excess bone mineralisation). Further, bone re-
modelling controls Ca2+ fluxes into and from the extracellular
fluid which is required for the maintenance of the levels of
calcium in blood [4]. Osteoclasts belong to the myeloid line-
age, are M-CSF (CSF-1)-dependent and are multinucleated.
Osteoclastogenesis is dependent on receptor activator of
NFκB ligands (RANKL). Osteoclasts attach to the bone sur-
face and assume a polarised morphology. The area attached to
the bone is sealed, bone is degraded by the release of acid and
acidic collagenolytic enzymes and released material is secret-
ed at the opposite side of the cell through transcytosis [4].
Exchange of signals between osteoblasts and osteoclasts en-
sures that bone remodelling is regulated [64]. For instance,
osteoblast apoptosis upon bone damage promotes osteoclast
recruitment to the bone surface and osteoblast-derived
RANKL is essential for osteoclast differentiation. IL-33 pro-
duced by osteoblasts inhibits osteoclast formation. Similarly,
osteoclasts influence osteoblast function through the produc-
tion of cardiotrophin-1 and semaphorin 4D (CD100), which
promote and inhibit bone formation, respectively [64]. As a
consequence of lack of bone resorption, bone marrow
haematopoiesis does not occur due to lack of its anatomical
niche. Csf1-deficient animals develop osteopetrosis and sur-
vive to adulthood because of extramedullary haematopoiesis
in the spleen and liver and generation of osteoclasts takes
place by compensatory expression of VEGF. Osteoclast gen-
eration enables the establishment of bone marrow
haematopoiesis by enabling the creation of the haematopoietic
niche [54].
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Remodelling deficiencies in the absence of macrophages
have been observed inmammary glands, kidney and pancreas,
which suggest an important role in morphogenesis; this can be
due to the contribution of macrophages to extracellular matrix
remodelling and a role in maintenance of the viability and
function of stem cells [73], as observed in mammary glands
and liver.
Macrophages and erythropoiesis
Definitive erythropoiesis occurs in the bone marrow; in par-
ticular, terminal erythropoiesis takes place in erythroblastic
islands where tight clusters can be found between erythroid
precursors with a central macrophage [8]. Molecules implicat-
ed in the interaction between erythroid precursors and macro-
phages include the erythroblast macrophage protein (Emp),
the haemoglobin-haptoglobin receptor CD163, VLA-4 on
erythroblasts and VCAM-1 on macrophages, and ICAM-4
on erythroblasts and αV integrin on macrophages.
Erythroblastic islands have also been found in areas of defin-
itive haematopoiesis such as foetal liver and splenic red pulp.
Macrophages have been shown to promote erythropoiesis
through the release of ferritin by exocytosis, which is
internalised by erythroblasts where iron is released through
acidification and proteolysis [15]; factors associated with
chronic inflammation such as IFN-ɣ, TNF-α, TGF-β and
IL-6 inhibit erythropoiesis [15]. Erythropoiesis is completely
dependent on the phagocytic activity of macrophages.
Macrophages phagocytose extruded erythrocyte nuclei which
are released during the final phase of erythrocyte differentia-
tion [15]. This is possible through the maintenance of adhe-
sion molecules such as Emp and β1 integrin and exposure of
phosphatidyl serine at the surface of the membrane-enveloped
nuclei [15].
Macrophages and brain development
Microglia constitute the resident macrophage population in
the brain and spinal cord and are yolk sac-derived. In addition
to responding to tissue injury, ramified microglia have been
shown to contribute to synaptic maturation during brain de-
velopment [58]. This process is termed Bsynaptic pruning^
and involves the clearance of immature or defective neuronal
synapses [1]; microglia dysfunction is now considered a major
cause of neuropsychiatric or neurological disorders as exem-
plified by the link between mutations in the gene encoding
CSF1R to hereditary diffuse leukoencephalopathy with spher-
oids [1]. Loss of function mutations in TREM-2, a receptor
expressed by microglia in the CNS, have been associated with
increased risk of developing late-onset Alzheimer’s disease
[75]. Microglia protect against extension of amyloid fibrils
by wrapping around amyloid-β plaques [11] and TREM-2
deficiency has been shown to disrupt this process [75].
Macrophages and lung homeostasis
Alveoli are lined by the alveolar epithelium which is mainly
composed of type I and type II alveolar epithelial cells. Type I
epithelial cells cover 90% of the alveoli surface while type II
epithelial cells are less abundant and mediate the synthesis,
secretion and recycling of lung surfactant [5, 46]. Alveolar
surfactant is composed of lipids and proteins and keeps alveoli
open by reducing surface tension during breathing. Alveolar
macrophages reside in the alveoli and establish close interac-
tions with alveolar epithelial cells, some of which involve
interactions such as CD200R-CD200 and CD47-SIPRα as
inhibitory receptors. Surfactant proteins A and D also contrib-
ute to inhibition of cellular activation in alveolar macrophages
by engaging SIRPα [37]. Alveolar macrophages are derived
from embryonically derived foetal monocytes soon after birth
through a process highly dependent on GM-CSF [18]. They
replicate in situ and, thus, are independent from monocyte
input in most instances [18]. Alveolar macrophages mediate
20–30% of surfactant lipid metabolism which explains the
development of pulmonary alveolar proteinosis in GM-CSF-
deficient mice and in mice lacking the ABC transporters
(ABC-A1, ABCG1 or peroxisome proliferator-activating re-
ceptor gamma (PPAR-ɣ) which display inefficient surfactant
catabolism in alveolar macrophages. These same genes are
involved in cholesterol metabolism and transport by circulat-
ing monocytes and their deficiency has been linked to the
development of atherosclerosis [46].
Macrophages and metabolism
Macrophages and metabolic syndrome
The involvement of macrophages in metabolic homeostasis
was highlighted by major changes in macrophage numbers
(10–15 to 45–60% of stromal cells) and phenotype (shift from
alternative activation to classical activation) in white adipose
tissue in obese insulin-resistant animals and humans [9, 17,
28, 49, 57]. These changes have also been observed in other
metabolic tissues, liver and muscle, which implies a strong
functional link between macrophage phenotype and parame-
ters of tissue homeostasis [49]. This is in agreement with mac-
rophages contributing actively to maintenance of tissue ho-
meostasis, but also acting as sensors of tissue dysfunction
and promoters of inflammation in the absence of infection.
In the case of the metabolic syndrome, the central role of
macrophages derives in part from the negative impact of in-
flammation on signalling events downstream of the insulin
receptor, making the cells within metabolic tissues resistant
to the action of insulin [49]. This effect in turn will lead to
maladaptation in glucose metabolism, with increased insulin
production by islet cells in the pancreas required to
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compensate for this inflammation-related effect and establish-
ment of a pre-diabetic state [49]. In healthy white adipose
tissue, insulin sensitivity in adipocytes is maintained through
the action of resident macrophages that express the anti-
inflammatory cytokine IL-10 acting as insulin sensitiser.
These adipose-tissue macrophages have a phenotype consis-
tent with alternative activation resulting from exposure to IL-4
and IL-13. PPAR-ɣ expression bymacrophages is essential for
control of alternative activation and improves insulin resis-
tance [56]; eosinophils have been identified as the source of
IL-4 in adipose tissue and lack of eosinophils has been asso-
ciated with activation of adipose tissue macrophages and a
tendency to develop insulin resistance in response to obesity
[72]. Changes in macrophage phenotype in white adipose tis-
sue after chronic increase in energy uptake occur in response
to metabolic stress in the adipocytes; this leads to the recruit-
ment of inflammatory monocytes by CCL2, CCL5 and CCL8
[73]. These inflammatory monocytes differentiate into classi-
cally activated macrophages, engulf dying adipocytes and fur-
ther promote cellular activation. Cytokine production by these
activated macrophages is considered major contributors to
local and systemic insulin resistance. In the case of hepatic
insulin resistance, Kupffer cells regulate the oxidation of fatty
acids in hepatocytes; hepatic steatosis develops if Kupffer
cells are unable to adopt an alternative activation phenotype
because of loss of PPAR-δ in myeloid cells [73].
Macrophages and iron recycling
Resident bone marrow macrophages and red pulp macro-
phages are essential for the process of erythrophagocytosis
to recycle iron. Senescent or damaged erythrocytes are phago-
cytosed and digested to extract heme [22]. Upon uptake, heme
is degraded through the action of heme oxygenase (HO;
predominantly HO-1) to release iron into the cytoplasm.
Cytoplasmic iron is exported by ferroportin located at the
plasma membrane [22, 33]. Iron flux from macrophages ex-
ceeds iron adsorption through diet and iron stored in hepato-
cytes [22]. Intriguingly, heme itself has been shown to induce
the development of F4/80hi, VCAMhi iron recycling macro-
phages in bone marrow and spleen through induction of the
transcription factor Spi-c [33]. Red pulp macrophages also
express Nramp1 and the haptoglobin-haemoglobin receptor
(CD163) which further emphasises their important role in sys-
temic iron haemostasis [22]. There are several hypotheses
regarding the signals recognised on aged erythrocytes bymac-
rophages for their removal. These signals include the exposure
of the universal apoptotic marker phosphatidyl serine in se-
nescent erythrocytes, in spite of the fact that erythrocytes lack
a cell nucleus and mitochondria and do not undergo canonical
apoptotic process [15]. Other possibilities include the loss of
CD47 expression, i.e. lack of an inhibitory signal, and confor-
mational changes in CD47 that enable an interaction between
CD47 and thrombospondin-1 which results in increased up-
take by red pulp macrophages [15]. Splenic macrophages
have also been implicated in the removal of intracellular in-
clusions in erythrocytes through a process that leaves the
erythrocyte intact. These inclusion bodies are thought to be
caused by oxidative damage [15].
Macrophages and tissue regeneration
Self-contained inflammation with preservation of organ func-
tion depends on multifaceted interactions between macro-
phages and recruited immune cells, particularly neutrophils
and monocytes that ensure timely resolution through changes
in the activation state of macrophages (from aM1 to aM2-like
phenotype). These constitute a Blipid mediator class switch^
which shifts the production of lipid mediators from pro-
inflammatory (for instance the eicosanoids prostaglandin E2,
and leukotriene B4 that promote vasodilatation and chemo-
taxis) to pro-resolving lipids (such as lipoxins, resolvins,
protectins and maresins), production of proteins such as
annexin A1, gaseous mediators (carbon monoxide), chemo-
kine inactivation and release of acetylcholine by the vagus
nerve [34]. Resident macrophages dominate the induction of
inflammatory responses in response to injury in the presence
and absence of infection through activation of receptors by
DAMPs and MAMPs. After stimulation, macrophages pro-
duce an array of cytokines such as TNF-α, IL-1β and IL-6
and chemokines as well as pro-inflammatory eicosanoids de-
rived from arachidonic acid, an omega-6 fatty acid.
Vasodilation and edema are followed by recruitment of neu-
trophils which are the first cells that enter the inflamed site.
Neutrophil recruitment is favoured by the rapid exposure of P-
selectin (CD62P) on activated endothelial cells followed by
engagement of β2 integrins by the adhesion molecules
ICAM-1 and ICAM-2, culminating in the process of diapede-
sis. Cues for directional cell migration are provided by the
formation of chemokine gradients that guide the migrating
neutrophil to the site of injury. Resolution of inflammation is
now viewed as an active process and its de-regulation can
hamper restoration of tissue function with lack of resolution
leading to chronic inflammation and scar formation and fibro-
sis. The collaborative nature of the resolution process is illus-
trated by the requirement for transcellular metabolic events
between leukocytes and epithelial cells and platelets for the
synthesis of lipoxins, the first described pro-resolving lipids.
Because of their potential for tissue damage, it appears coun-
terintuitive to consider neutrophils’ essential partners for the
resolution of inflammation. However, neutrophils promote
resolution by enhancing monocyte recruitment by inducing
changes in endothelial cells, for instance through shedding
of IL-6Rα which complexes with IL-6. The IL-6Rα-IL-6
complex engages gp130 on endothelial cells and induces the
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production of E-selectin (CD62E) and VCAM1, thus promot-
ing monocyte recruitment. In addition, apoptotic neutrophils
change macrophage activation as uptake of apoptotic neutro-
phils is non-phlogistic, inducing IL-10, TGF-β and lipoxin
synthesis by macrophages [66]. These changes are associated
with the sensing of an Binflammation threshold^ established
early during the induction phase and highly dependent on the
nature and extent of the original insult. Molecular mechanisms
underpinning this concept include the fact that prostaglandin
E2 induces changes in the lipoxygenase activity of neutrophils
from 5-lipoxygenase to 15-lipoxygenase, required for synthe-
sis of lipoxins [34]. During cardiac damage, inflammatory
neutrophils and monocytes release oncostatin-M that induces
the release by cardiomyocytes of Reg3β. Reg3β promotes the
recruitment of reparative macrophages which favours the
elimination of neutrophils [26]. In addition, macrophages con-
trol the neutrophil lifespan through the release of TNF-α, Fas
ligand (FasL) and TRAIL [34].
The fate of the recruited monocytes and their contribution
to repair depends on the organ and extent of damage. In the
heart, recruited monocytes give rise to pro-inflammatory mac-
rophages, while resident macrophages mediate tissue repair.
In the spinal cord, both the pro-inflammatory and repair mac-
rophages are monocyte-derived. While the pro-inflammatory
macrophages derive from monocytes recruited through the
CCR2-CCL2 pathway, repair-promoting macrophages de-
rived frommonocytes are recruited through a pathway involv-
ing VLA-4, VCAM-1 and CD73 [26]. In other scenarios,
recruited monocytes have been shown to convert from an
initial pro-inflammatory (M1) phenotype to a healing, pro-
resolving (M2) phenotype [14, 60] consistent with plasticity
of myeloid cells. This scenario has been observed in kidney
[45] and muscle [3].
A key aspect during tissue regeneration and repair is the
cross-talk between macrophages and stem cells. For instance,
in liver, macrophage depletion has been shown to reduce in-
vasiveness of liver progenitor cells into the parenchymawhich
is required for differentiation into hepatocytes [10]. In addi-
tion, macrophages can be induced to produce Wnt3a after
uptake of hepatic debris. Wnt3a promotes expression of
Numb in liver progenitor cells which inhibits Notch and pro-
motes differentiation into hepatocytes instead of biliary cells
[10]. Macrophages contribute to muscle regeneration with the
sequential change from an early M1-like phenotype into a
M2-like phenotype, essential for this process. Disruption of
these changes in the phenotype of macrophages by blocking
early inflammation (treatment with IL-10 or blocking IFN-ɣ)
or late resolution (treatment with anti-IL-10) compromises
muscle regeneration. Myogenic precursor cells are stimulated
to migrate, grow and survive by macrophages with M1 cells
stimulating proliferation and inhibiting fusion and M2 macro-
phages stimulating commitment of myogenic precursors and
differentiation to formmyotubes [10]. In kidney, macrophages
have been found to produce Wnt7b which promotes repair of
basement membrane [10].
Scar formation during wound healing can compromise or-
gan function after injury and multiple reports have linked Th2
immunity to the regulation of tissue fibrosis, although the
molecular processes of this effect are poorly understood [24,
74]. Knipper et al. [42] recently revealed an important cross-
talk between macrophages and fibroblasts during wound
healing in mouse injured skin, required to control the forma-
tion of collagen fibrils. This effect is dependent on the expres-
sion of IL-4-Rα by myeloid cells which, among others, in-
duces the production of Relm-α, a well-characterised marker
of macrophage activation in response to IL-4. IL-4Rα signal-
ling during wound healing promotes the expression of
Relm-α by macrophages, and Relm-α, in turn, induces the
synthesis of the collagen-modifying enzyme lysyl hydroxy-
lase 2 by fibroblasts, leading to fibrosis [42]. In line with the
major influence of the tissue environment on macrophage bi-
ology, in liver and muscle, Th2 immunity promotes tissue
regeneration through direct action on parenchymal cells [27,
36]; this suggests that macrophage contribution to wound
healing is largely dependent on the intrinsic regenerative ca-
pacity of the tissue and, likely, the nature of the insult.
Macrophages and thermogenesis
Brown fat, termed brown adipose tissue, generates heat
(thermogenesis) and plays an important role in maintaining
body temperature. In contrast to white adipocytes, brown ad-
ipocytes contain multilocular fat droplets, a large number of
mitochondria, and express high levels of UCP1 (uncoupling
protein 1). UCP1 is located in the inner membrane of the
mitochondria and uncouples electron transport to promote
heat instead of ATP in brown adipocytes. In humans, brown
adipose tissue was thought to be restricted to neonates but
recent data have shown the presence of brown fat in adults
[12, 41, 69]. Adult human brown fat is dispersed in the
supraclavicular, para-aortic and suprarenal regions, is cold-
inducible and shares many characteristic with the cold-
inducible beige fat found in the subcutaneous white adipose
tissue of rodents [61]. Beige fat refers to the presence of white
adipocytes functionally similar to brown adipocytes within
white fat and promotion of beige fat formation is considered
as a potential therapeutic tool in the fight against obesity [41].
Macrophages have been shown to be essential for adaptation
to cold exposure that leads to lipolysis in white fat and ther-
mogenesis in brown fat. The effect of macrophages depends
on the acquisition of an alternative activated phenotype driven
by lL-4/IL-13 and Stat-6 and that leads to secretion of cate-
cholamines by these cells [53]. Indeed, IL-4 exposure of mac-
rophages induces production of the three enzymes required for
catecholamine production: tyrosine hydroxylase, dopa
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decarboxylase and dopamine β-hydroxylase [53]; the β3-
adrenergic agonist CL-316246 was able to rescue the thermo-
genic defect in animals unable to produce IL-4 and IL-13 [53].
In agreement with these findings in mice, oral administration
of the β3-adrenergic receptor agonist mirabegron can stimu-
late human brown fat thermogenesis in humans [13].
Macrophages, together with eosinophils and Th2 cytokines,
have also been implicated in the remodelling of subcutaneous
white fat into beige fat in mice [61].
Conclusion and therapeutic opportunities
Macrophages are remarkable for their ability to sense their
surroundings, produce a wide range of immune mediators
alongside growth factors and opsonins, and their endocytic
and phagocytic activity. The recognition of macrophages as
intrinsic components of organs, adapted to the particular tis-
sue environment and actively involved in homeostatic pro-
cesses, opens the opportunity for macrophage-centred ther-
apies that can be exploited to steer pathological processes
towards outcomes that favour maintenance of organ func-
tion. Furthermore, the potential plasticity shown by these
cells [44] makes it possible to envisage the possibility of
using in vitro-differentiated cells to treat disease by adoptive
transfer.
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